Area of research
Otorhinolaryngology · Cancer Research
Research interest
Research interests include Head and Neck Cancer Studies, Cancer Genomics and Diagnostics, Radiomics and Machine Learning in Medical Imaging, and Cancer Immunotherapy and Biomarkers.
Investigating Early Kinetics in Plasma ctDNA and Peripheral T-cell Receptor Repertoire to Predict Treatment Outcomes to PD-1 Inhibitors in Head and Neck Squamous Cell Carcinoma.
Exploring the Utility of Cell-Free DNA Hydroxymethylation Profiling in Small-Cell Lung Cancer
Data from Investigating Early Kinetics in Plasma ctDNA and Peripheral T-cell Receptor Repertoire to Predict Treatment Outcomes to PD-1 Inhibitors in Head and Neck Squamous Cell Carcinoma
Supplementary Figures 1 from Investigating Early Kinetics in Plasma ctDNA and Peripheral T-cell Receptor Repertoire to Predict Treatment Outcomes to PD-1 Inhibitors in Head and Neck Squamous Cell Carcinoma
Supplementary Tables 1 from Investigating Early Kinetics in Plasma ctDNA and Peripheral T-cell Receptor Repertoire to Predict Treatment Outcomes to PD-1 Inhibitors in Head and Neck Squamous Cell Carcinoma
Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer.
Association between Locoregional Failure and NFE2L2/KEAP1/CUL3 Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer.
Circulating human papillomavirus DNA sequencing as a biomarker of response in advanced cervical cancer
Cross-ancestral GWAS identifies 29 variants across head and neck cancer subsites
Adaptive Universal Principles for Real-world Observational Studies (AUPROS): an approach to designing real-world observational studies for clinical, epidemiologic, and precision oncology research.
Data from Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer
Supplementary Data 1 from Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer
Positron Emission Tomography/Computed Tomography (PET/CT) and Radioimmunotherapy of Head and Neck Cancer Patient Derived Xenografts in NRG Mice with Theranostic [<sup>64</sup>Cu]Cu-DOTA-Panitumumab F(ab')<sub>2</sub> and [<sup>177</sup>Lu]Lu-DOTA-Panitumumab F(ab')<sub>2</sub>.
Supplementary Table 1 from Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer
Supplementary Table S1 from Association between Locoregional Failure and <i>NFE2L2/KEAP1/CUL3</i> Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer
Supplementary Figure 3 from Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer
Supplementary Table S8 from Association between Locoregional Failure and <i>NFE2L2/KEAP1/CUL3</i> Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer
Supplementary Table S3 from Association between Locoregional Failure and <i>NFE2L2/KEAP1/CUL3</i> Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer
Outcomes and characteristics of patients receiving pre-operative versus post-operative radiotherapy for sinonasal squamous cell carcinoma.
Supplementary Table 6 from Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer
Supplementary Table S5 from Association between Locoregional Failure and <i>NFE2L2/KEAP1/CUL3</i> Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer
Supplementary Table S2 from Association between Locoregional Failure and <i>NFE2L2/KEAP1/CUL3</i> Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer
Supplementary Table S6 from Association between Locoregional Failure and <i>NFE2L2/KEAP1/CUL3</i> Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer
Supplementary Table 5 from Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer
Supplementary Figure 1 from Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer
Supplementary Figure S2 from Association between Locoregional Failure and <i>NFE2L2/KEAP1/CUL3</i> Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer
Supplementary Table S7 from Association between Locoregional Failure and <i>NFE2L2/KEAP1/CUL3</i> Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer
Supplementary Table 3 from Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer
Supplementary Table 7 from Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer
Data from Association between Locoregional Failure and <i>NFE2L2/KEAP1/CUL3</i> Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer